By Andreas Wallnöfer, General Partner of Biomed Partners VC, Executive Advisor to Certara, and former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche. Even when we can...
News & Events
Optimizing COVID‐19 candidate therapeutics: Thinking Without Borders
This commentary in Clinical and Translational Science by Drs. Craig R. Rayner, Patrick F. Smith, Kevin Hershberger, and David Wesche shares insights from past experiences with H5N1 and pH1N1 outbreaks...
Event: Accelerating Therapeutics for COVID-19 Webinar on April 8
Speaker(s): Dr. Dan Hartman, Director of Integrated Development, Bill & Melinda Gates Foundation Dr. Steven Kern, Deputy Director of Quantitative Sciences, Bill & Melinda Gates Foundation Dr...